MedPath

Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital

Active, not recruiting
Conditions
Hypercalcemia
Registration Number
NCT06467877
Lead Sponsor
University of Cologne
Brief Summary

Patients with hypercalcemia were identified in the patient population of a German emergency department during a 11 year time period and studied regarding reproducibility of elevated calcium values, causes of hypercalcemia, symptoms. acute renal injury, mortality and treatment response.

Detailed Description

Patients, who presented to the emergency department of a tertiary German hospital with a total calcium of ≥2.65 mmol/l between January 2010 and March 2021, was retrospectively studied. From the electronic patient records we analyzed if the elevated calcium values were reproducible in follow-up measurements, identified the cause of hypercalcemia, listed the symptoms, investigated a correlation between calcium and creatinine values to study acute renal injury directly due to hypercalcemia, calculated the mortality rate stratified by the calcium value on presentation and studied the treatment response regarding lowering calcium values by different treatments.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age > 18 years
  • Total calcium ≥ 2.65 mmol/l
  • Female and male
Read More
Exclusion Criteria
  • Age < 18 years
  • Total calcium < 2.65 mmol/
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of total calcium values5 days after enrollment

Overview of total calcium values within 5 days

Secondary Outcome Measures
NameTimeMethod
Reproducibility of elevated calcium values5 days after enrollment

Determination of cause of hypercalcemia, of symptoms, of treatment response. In dependence of hospital stay, kann be determined later than 5 days after enrollment

Correlation creatinine calcium5 days after enrollment

Determination of correlation between calcium and creatinine.

Mortality5 days after enrollment

occurence of death within of 5 days after enrollment

Trial Locations

Locations (1)

Department II of Internal Medicine,University of Cologne

🇩🇪

Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath